D68.5
Primary thrombophilia
Clinical Classification Guidelines
Inclusion Terms
- Primary hypercoagulable states
Excludes Type 1
- antiphospholipid syndrome (D68.61)
- lupus anticoagulant (D68.62)
- secondary activated protein C resistance (D68.69)
- secondary antiphospholipid antibody syndrome (D68.69)
- secondary lupus anticoagulant with hypercoagulable state (D68.69)
- secondary systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (D68.69)
- systemic lupus erythematosus [SLE] inhibitor finding without diagnosis (R76.0)
- systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder (D68.312)
- thrombotic thrombocytopenic purpura (M31.19)
Medical Intelligence & Overview
Primary thrombophilia, classified under ICD-10 code D68.5, refers to a group of inherited blood clotting disorders that increase the risk of abnormal blood clots forming in blood vessels. These conditions are also known as primary hypercoagulable states. They can affect individuals of all ages and may lead to complications such as deep vein thrombosis (DVT) and pulmonary embolism. Understanding the causes, symptoms, diagnosis, and management options is essential for individuals diagnosed with this condition, although specific medical advice should always be sought from healthcare professionals.
Causes & Symptoms
Clinical Causes: Inherited genetic mutations that affect blood clotting factors, such as Factor V Leiden mutation, prothrombin gene mutation, or deficiencies in proteins C, S, or antithrombin III. A family history of thrombophilia or blood clotting disorders. Certain inherited conditions that predispose individuals to hypercoagulability. Less commonly, acquired conditions may trigger a hypercoagulable state, but primary thrombophilia specifically refers to inherited causes.
Key Symptoms: Swelling, pain, or tenderness in the affected limb, often the leg (deep vein thrombosis). Redness or warmth over the affected area. Sudden shortness of breath or chest pain if a clot breaks free and moves to the lungs (pulmonary embolism). Unexplained blood clots in veins or arteries. In some cases, there may be no noticeable symptoms until a clot causes an issue.
Diagnostic & Treatment
Diagnosis Path: Diagnosing primary thrombophilia involves a combination of blood tests and clinical evaluations. These may include:
Treatment Protocols: While primary thrombophilia cannot be cured, management focuses on reducing the risk of clot formation and preventing complications. Treatment strategies include:
Clinical Advice & FAQs
Billing Guidance
Is D68.5 a billable ICD-10 code?
Yes, D68.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D68.5?
Clinical documentation must specify the nature of Primary thrombophilia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference